Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
肽治疗后 Fel d 1 特异性 T 细胞的频率和表型
基本信息
- 批准号:8325192
- 负责人:
- 金额:$ 67.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-09 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAffinityAllergensAllergic DiseaseAllergic rhinitisArchivesAsthmaBindingBloodCell physiologyClinicalClinical TrialsDevelopmentDiseaseExtrinsic asthmaFelis catusFreezingFrequenciesFutureGenesHLA-DR4 AntigenHumanHypersensitivityImmunotherapyInstructionInvestigational TherapiesMHC Class II GenesMagnetismMemoryMolecular ProfilingMusPeptide VaccinesPeptide/MHC ComplexPeptidesPeripheral Blood Mononuclear CellPhase II Clinical TrialsPhenotypePublic HealthReagentRegulatory T-LymphocyteResearch ProposalsSeveritiesT-LymphocyteT-Lymphocyte EpitopesVaccineschemokine receptorclinical efficacyhuman subjectnovelprospectivereceptor expressiontreatment durationvaccine development
项目摘要
PROJECT SUMMARY (See instructions):
The broad, long term objective of this research proposal is to understand how peptide immunotherapy, using validated T cell epitopes of a major allergen (Fel d 1), modulates the frequency and functional phenotype of Fel d 1-specific T cells, using unique MHC Class II tetramer reagents.
We hypothesize that peptide immunotherapy results in modulation of the frequency and functional phenotype of allergen-specific T cells following peptide immunotherapy.
Specific Aim 1 will determine the effects of peptide immunotherapy (PIT) on Fel d 1-specific (tetramer+) T cells in subjects with cat allergic asthma of increasing severity. An archive of frozen peripheral blood mononuclear cells (PBMC) collected from a Phase II clinical trial of peptide immunotherapy in subjects with cat allergic asthma (groups stratified for severity) will be used to determine the frequency and functional phenotype of allergen-specific (MHC class II tetramer+) T cells.
Specific Aim 2 will employ a prospective clinical trial of peptide immunotherapy in cat allergic rhinitis. Large volumes (200ml) of blood will be drawn at baseline, shortly after the end of treatment (week 18-22) and one year after the initiation of the study. Tetramer+ T cells will be enriched using sequential magnetic purification
to determine whether peptide immunotherapy changes frequency, memory phenotype, chemokine receptor expression and markers of regulatory T cell function among allergen-specific tetramer+ T cells.
Specific Aim 3 will address how the affinity of vaccine peptides for the MHC affects the clinical efficacy of the peptide (its ability to induce immunological tolerance). This study cannot be performed in human subject due to the complexity of MHC molecules expressed and because each peptide binds to multiple MHC molecules.
Therefore the study will be conducted in mice that express the human MHC gene, HLA-DR4. The 7 peptides comprising the peptide vaccine employed in Aims 1 & 2 have differing affinity for HLA-DR4. Each peptide will be evaluated to determine how efficacy relates to affinity.
项目总结(见说明):
这项研究提案的广泛和长期目标是了解多肽免疫疗法如何利用主要过敏原(FEL D 1)的有效T细胞表位,使用独特的MHC II类四聚体试剂来调节FEL d 1特异性T细胞的频率和功能表型。
我们假设,在多肽免疫治疗之后,多肽免疫治疗导致了过敏原特异性T细胞的频率和功能表型的调节。
特定目的1将确定多肽免疫疗法(PIT)对猫过敏性哮喘日益严重的受试者FEL-1特异性(四聚体+)T细胞的影响。从猫过敏性哮喘患者多肽免疫治疗的II期临床试验(按严重程度分组)中收集的冷冻外周血单个核细胞(PBMC)档案将用于确定过敏原特异性(MHC II类四聚体+)T细胞的频率和功能表型。
特定目的2将采用多肽免疫疗法治疗猫变应性鼻炎的前瞻性临床试验。在治疗结束后不久(第18-22周)和研究开始一年后,将在基线上抽取大量血液(200毫升)。四聚体+T细胞将通过顺序磁净化进行浓缩
目的:确定多肽免疫治疗是否改变变应原特异性四聚体+T细胞的频率、记忆表型、趋化因子受体表达和调节T细胞功能的标志物。
具体目标3将阐述疫苗多肽与MHC的亲和力如何影响多肽的临床疗效(其诱导免疫耐受的能力)。由于表达的MHC分子的复杂性,以及每个肽都与多个MHC分子结合,这项研究不能在人体内进行。
因此,这项研究将在表达人类MHC基因人类白细胞抗原-DR4的小鼠身上进行。AIMS 1和AIMS 2中使用的7种多肽疫苗对人类白细胞抗原DR4具有不同的亲和力。将对每种多肽进行评估,以确定疗效与亲和力的关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Larche其他文献
Mark Larche的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Larche', 18)}}的其他基金
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
肽疗法和过敏原激发对 Fel d1 特异性 T 细胞的影响
- 批准号:
8651874 - 财政年份:2012
- 资助金额:
$ 67.89万 - 项目类别:
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
肽疗法和过敏原激发对 Fel d1 特异性 T 细胞的影响
- 批准号:
8822807 - 财政年份:2012
- 资助金额:
$ 67.89万 - 项目类别:
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
肽疗法和过敏原激发对 Fel d1 特异性 T 细胞的影响
- 批准号:
8453235 - 财政年份:2012
- 资助金额:
$ 67.89万 - 项目类别:
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
肽疗法和过敏原激发对 Fel d1 特异性 T 细胞的影响
- 批准号:
8305844 - 财政年份:2012
- 资助金额:
$ 67.89万 - 项目类别:
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
肽治疗后 Fel d 1 特异性 T 细胞的频率和表型
- 批准号:
8453237 - 财政年份:
- 资助金额:
$ 67.89万 - 项目类别:
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
肽治疗后 Fel d 1 特异性 T 细胞的频率和表型
- 批准号:
9037572 - 财政年份:
- 资助金额:
$ 67.89万 - 项目类别:
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
肽治疗后 Fel d 1 特异性 T 细胞的频率和表型
- 批准号:
8651875 - 财政年份:
- 资助金额:
$ 67.89万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 67.89万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 67.89万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 67.89万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 67.89万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 67.89万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 67.89万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 67.89万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 67.89万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 67.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 67.89万 - 项目类别:
Studentship